JP2008542297A5 - - Google Patents

Download PDF

Info

Publication number
JP2008542297A5
JP2008542297A5 JP2008513760A JP2008513760A JP2008542297A5 JP 2008542297 A5 JP2008542297 A5 JP 2008542297A5 JP 2008513760 A JP2008513760 A JP 2008513760A JP 2008513760 A JP2008513760 A JP 2008513760A JP 2008542297 A5 JP2008542297 A5 JP 2008542297A5
Authority
JP
Japan
Prior art keywords
hydroxy
composition
pentamethoxyflavone
tetramethoxyflavone
hexamethoxyflavone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008513760A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008542297A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/020441 external-priority patent/WO2006127996A2/en
Publication of JP2008542297A publication Critical patent/JP2008542297A/ja
Publication of JP2008542297A5 publication Critical patent/JP2008542297A5/ja
Pending legal-status Critical Current

Links

JP2008513760A 2005-05-24 2006-05-24 運動回復を最適化するための組成物及び方法 Pending JP2008542297A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68433605P 2005-05-24 2005-05-24
PCT/US2006/020441 WO2006127996A2 (en) 2005-05-24 2006-05-24 Compositions and methods for optimizing exercise recovery

Publications (2)

Publication Number Publication Date
JP2008542297A JP2008542297A (ja) 2008-11-27
JP2008542297A5 true JP2008542297A5 (enExample) 2009-07-30

Family

ID=37452884

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008513760A Pending JP2008542297A (ja) 2005-05-24 2006-05-24 運動回復を最適化するための組成物及び方法

Country Status (8)

Country Link
US (2) US20070042972A1 (enExample)
EP (1) EP1883300A2 (enExample)
JP (1) JP2008542297A (enExample)
CN (1) CN101227818A (enExample)
AU (1) AU2006249825A1 (enExample)
BR (1) BRPI0611502A2 (enExample)
CA (1) CA2608657A1 (enExample)
WO (1) WO2006127996A2 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2010194A4 (en) * 2006-03-15 2010-03-03 Univ Rutgers HYDROXYLATED POLYMETHOXYFLAVONE COMPOSITIONS
US20090083136A1 (en) * 2007-09-21 2009-03-26 Scott Kyle Blackwood Consolidating online purchase transactions
JP5225285B2 (ja) * 2007-11-02 2013-07-03 三栄源エフ・エフ・アイ株式会社 呈味改善剤
JP2013515500A (ja) 2009-12-29 2013-05-09 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド 炎症性の病気の改善または予防のための、ショウガが含まれる組成物
US8602988B2 (en) * 2010-02-02 2013-12-10 Recovery Science and Technology, LLC Recovery determination methods and recovery determination apparatuses
US8481099B2 (en) * 2011-09-12 2013-07-09 Del Monte Corporation Process for conversion of citrus peels into fiber, juice, naringin, and oil
US20160100615A1 (en) 2014-10-10 2016-04-14 Sudarshan Narasimhan Hunger minimized juice fasting system
EP4257204A3 (en) 2015-02-11 2023-11-29 BioActor B.V. Compounds and compositions for improving power output and oxygen efficiency
JP6674766B2 (ja) * 2015-11-27 2020-04-01 日清オイリオグループ株式会社 馬用飼料添加剤
FR3050737B1 (fr) * 2016-04-27 2018-04-06 Societe D'exploitation De Produits Pour Les Industries Chimiques Seppic Procede d'evaluation de la capacite d'une composition a prevenir la fatigue et les dommages musculaires ; nouveau complement alimentaire et medicament.
US11357250B2 (en) 2016-08-15 2022-06-14 Summit Innovation Labs LLC Treatment and prevention of diabetes and obesity

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2002A (en) * 1841-03-12 Tor and planter for plowing
US3657424A (en) * 1970-04-01 1972-04-18 Florida State Full-flavored citrus juice energy supplement
JP2003509447A (ja) * 1999-09-21 2003-03-11 ラトガーズ,ザ ステイト ユニバーシティ 癌の予防および治療のためのオレンジの皮の抽出物
US20020037855A1 (en) * 2000-05-05 2002-03-28 Fritz Stanislaus Stabilized medicament containing cysteinyl derivatives
ES2260245T3 (es) * 2000-06-23 2006-11-01 Bodymedia, Inc. Sistema para controlar la salud, el bienestar y el ejercicio.
MXPA03002551A (es) * 2000-09-22 2004-08-12 Mars Uk Ltd Suplemento alimenticio.
EP1578401A4 (en) * 2002-04-22 2009-03-25 Rtc Res & Dev Llc COMPOSITIONS AND METHODS FOR PROMOTING LOSS OF WEIGHT, THERMOGENESIS, APPETIZING, SLIM MUSCLES, INCREASING METABOLISM AND ENHANCING ENERGY LEVELS, AND USE AS SUPPLEMENTS FOR MAMMALS
US7445807B2 (en) * 2002-10-15 2008-11-04 Western Holdings, Llc Agglomerated granular protein-rich nutritional supplement
JP2004210682A (ja) * 2002-12-27 2004-07-29 Ehime Prefecture カンキツ機能性成分高含有組成物の製造方法
US20050187176A1 (en) * 2003-10-10 2005-08-25 Bates Paula J. Method for inhibiting NF-kappa B signaling and use to treat or prevent human diseases
AU2005247159B2 (en) * 2004-05-26 2015-07-23 Interhealth Nutraceuticals Incorporated Pharmaceutical products for treating neoplastic disease and inflammation

Similar Documents

Publication Publication Date Title
Holick High prevalence of vitamin D inadequacy and implications for health
JP2010522190A5 (enExample)
JP2005501061A (ja) 免疫機能損傷患者の為の栄養療法
JP2014533729A (ja) ケルセチンを含有するc型肝炎ウイルスの感染を治療するための医薬品
JP2015131825A5 (enExample)
Konrad et al. Evaluation of quercetin as a countermeasure to exercise-induced physiological stress
ATE537828T1 (de) Psychotropes mittel und nahrungsmittel zur förderung der gesundheit enthaltend neferin
JP2003508467A5 (enExample)
JP2019532986A5 (enExample)
JP2005239581A (ja) 心筋炎の予防、治療又は改善用組成物
JP5846350B2 (ja) 骨疾患予防又は治療用組成物
WO2019183028A1 (en) Nutritional product and method of using it
JP2013540133A5 (enExample)
JP2007516991A5 (enExample)
Lu Antioxidants in the treatment of chronic liver diseases: why is the efficacy evidence so weak in humans?
JP3860133B2 (ja) ダイエット食品
CN101227818A (zh) 用于优化运动恢复的组合物和方法
KR100406837B1 (en) Health food composition containing natural product extract for reducing blood glucose level through the promotion of insulin release
WO2006065841A3 (en) Methods for enhancing the palatability of food compositions
CA3102947A1 (en) Nutraceuticals useful in the treatment of coronavirus diseases
JP2010090097A (ja) 抗骨粗鬆症組成物
JPH10158183A (ja) 二日酔いの予防および治療用組成物
ES2343119T3 (es) Composicion para la activacion del sistema inmune.
JP3851668B2 (ja) 医薬用組成物
JP5891694B2 (ja) 内用液剤組成物